FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605488888> ?p ?o ?g. }

• W2605488888 endingPage "701" @default.
• W2605488888 startingPage "695" @default.
• W2605488888 abstract "BACKGROUND Induction of anaesthesia with propofol and remifentanil often induces unwanted bradycardia and hypotension, raising concerns regarding tissue oxygenation. The electrophysiological cardiac effects of remifentanil can be reversed by atropine. OBJECTIVE To investigate if prophylactic administration of atropine can attenuate the negative haemodynamic effects of propofol and a high dose of remifentanil during induction of anaesthesia. DESIGN A double-blind, randomised controlled trial. SETTING Single-centre, University Medical Center Groningen, The Netherlands. PATIENTS Sixty euvolaemic patients scheduled for surgery under general anaesthesia. INTERVENTIONS Anaesthesia was induced and maintained with a target-controlled infusion of propofol with a target effect-site concentration (Ce) of 2.5 μg ml−1, remifentanil (target-controlled infusion), (Ce 8 ng ml−1) and cis-atracurium. Methylatropine (500 μg) or 0.9% saline was administered at immediately before induction of anaesthesia. MAIN OUTCOME MEASURES The changes (Δ) in mean arterial pressure (MAP), heart rate (HR), cardiac index (CI), rate pressure product, cerebral tissue oxygenation and peripheral tissue oxygenation between induction of anaesthesia (T0) and 10 min later (T10). RESULTS Atropine significantly attenuated the changes in the outcome measures between T0 and T10. Median (inter-quartile range) changes were MAP, Δ = −24 (−40 to −21) vs. Δ = −37 mmHg (−41 to −31) (P = 0.02); HR, Δ = 0 ± 13 vs. −19 ± 11 bpm (P < 0.01); CI, Δ = −0.4 ± 0.7 vs. −0.9 ± 0.6l min−1 m−2 (P < 0.01) and rate pressure product, Δ = −3241 (−5015 to −613) vs. Δ = −5712 mmHg min−1 (−6715 to −3917) (P < 0.01). Cerebral tissue oxygenation and peripheral tissue oxygenation did not change in either group. Maximum HR after atropine was 102 (86 to 116) vs. 85 bpm (76 to 95). CONCLUSION Administration of atropine, before induction of anaesthesia with propofol and high-dose remifentanil, can significantly reduce the decreases in HR, MAP and CI. TRIAL REGISTRATION Clinicaltrials.gov identifier: NCT01871922." @default.
• W2605488888 created "2017-04-28" @default.
• W2605488888 creator A5010652400 @default.
• W2605488888 creator A5032813813 @default.
• W2605488888 creator A5033751439 @default.
• W2605488888 creator A5048910956 @default.
• W2605488888 creator A5051340427 @default.
• W2605488888 creator A5076158642 @default.
• W2605488888 creator A5090963995 @default.
• W2605488888 date "2017-10-01" @default.
• W2605488888 modified "2023-09-27" @default.
• W2605488888 title "Prophylactic atropine administration attenuates the negative haemodynamic effects of induction of anaesthesia with propofol and high-dose remifentanil" @default.
• W2605488888 cites W1486239158 @default.
• W2605488888 cites W1965614042 @default.
• W2605488888 cites W1973682246 @default.
• W2605488888 cites W1979184820 @default.
• W2605488888 cites W2008594075 @default.
• W2605488888 cites W2024687868 @default.
• W2605488888 cites W2028141385 @default.
• W2605488888 cites W2033169320 @default.
• W2605488888 cites W2060316139 @default.
• W2605488888 cites W2064658153 @default.
• W2605488888 cites W2069216248 @default.
• W2605488888 cites W2072500831 @default.
• W2605488888 cites W2096732105 @default.
• W2605488888 cites W2115473091 @default.
• W2605488888 cites W2122877340 @default.
• W2605488888 cites W2135520127 @default.
• W2605488888 cites W2135537490 @default.
• W2605488888 cites W2139970973 @default.
• W2605488888 cites W2146660727 @default.
• W2605488888 cites W2149784416 @default.
• W2605488888 cites W2404519819 @default.
• W2605488888 cites W2426852239 @default.
• W2605488888 cites W2488700677 @default.
• W2605488888 cites W3165153188 @default.
• W2605488888 cites W4236805817 @default.
• W2605488888 cites W4250511173 @default.
• W2605488888 cites W4254194492 @default.
• W2605488888 doi "https://doi.org/10.1097/eja.0000000000000639" @default.
• W2605488888 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28403018" @default.
• W2605488888 hasPublicationYear "2017" @default.
• W2605488888 type Work @default.
• W2605488888 sameAs 2605488888 @default.
• W2605488888 citedByCount "14" @default.
• W2605488888 countsByYear W26054888882018 @default.
• W2605488888 countsByYear W26054888882019 @default.
• W2605488888 countsByYear W26054888882020 @default.
• W2605488888 countsByYear W26054888882021 @default.
• W2605488888 countsByYear W26054888882023 @default.
• W2605488888 crossrefType "journal-article" @default.
• W2605488888 hasAuthorship W2605488888A5010652400 @default.
• W2605488888 hasAuthorship W2605488888A5032813813 @default.
• W2605488888 hasAuthorship W2605488888A5033751439 @default.
• W2605488888 hasAuthorship W2605488888A5048910956 @default.
• W2605488888 hasAuthorship W2605488888A5051340427 @default.
• W2605488888 hasAuthorship W2605488888A5076158642 @default.
• W2605488888 hasAuthorship W2605488888A5090963995 @default.
• W2605488888 hasConcept C126322002 @default.
• W2605488888 hasConcept C178853913 @default.
• W2605488888 hasConcept C26170363 @default.
• W2605488888 hasConcept C2775859210 @default.
• W2605488888 hasConcept C2776277131 @default.
• W2605488888 hasConcept C2776452961 @default.
• W2605488888 hasConcept C2776983577 @default.
• W2605488888 hasConcept C2777495988 @default.
• W2605488888 hasConcept C2777953023 @default.
• W2605488888 hasConcept C2778891214 @default.
• W2605488888 hasConcept C42219234 @default.
• W2605488888 hasConcept C71924100 @default.
• W2605488888 hasConcept C84393581 @default.
• W2605488888 hasConceptScore W2605488888C126322002 @default.
• W2605488888 hasConceptScore W2605488888C178853913 @default.
• W2605488888 hasConceptScore W2605488888C26170363 @default.
• W2605488888 hasConceptScore W2605488888C2775859210 @default.
• W2605488888 hasConceptScore W2605488888C2776277131 @default.
• W2605488888 hasConceptScore W2605488888C2776452961 @default.
• W2605488888 hasConceptScore W2605488888C2776983577 @default.
• W2605488888 hasConceptScore W2605488888C2777495988 @default.
• W2605488888 hasConceptScore W2605488888C2777953023 @default.
• W2605488888 hasConceptScore W2605488888C2778891214 @default.
• W2605488888 hasConceptScore W2605488888C42219234 @default.
• W2605488888 hasConceptScore W2605488888C71924100 @default.
• W2605488888 hasConceptScore W2605488888C84393581 @default.
• W2605488888 hasIssue "10" @default.
• W2605488888 hasLocation W26054888881 @default.
• W2605488888 hasLocation W26054888882 @default.
• W2605488888 hasOpenAccess W2605488888 @default.
• W2605488888 hasPrimaryLocation W26054888881 @default.
• W2605488888 hasRelatedWork W2060231661 @default.
• W2605488888 hasRelatedWork W2076129754 @default.
• W2605488888 hasRelatedWork W2109477635 @default.
• W2605488888 hasRelatedWork W2348423746 @default.
• W2605488888 hasRelatedWork W2390473493 @default.
• W2605488888 hasRelatedWork W2412661860 @default.
• W2605488888 hasRelatedWork W2422389823 @default.
• W2605488888 hasRelatedWork W2605488888 @default.
• W2605488888 hasRelatedWork W2615356009 @default.

• next